Skip to main content
. Author manuscript; available in PMC: 2017 Aug 15.
Published in final edited form as: Head Neck. 2016 Feb 13;38(7):1008–1016. doi: 10.1002/hed.24403

Figure 5.

Figure 5

Analysis of overall survival (OS) of patients with head and neck adenoid cystic carcinoma (HNACC) based on CTA expression status. Patients positive for both pan-Melanoma antigen (pan-MAGE) and New York esophageal squamous cell carcinoma (NY-ESO-1) show significantly worse (p=0.047) OS than patients with negative expression status